Answers are grounded in this paper and cite their sources.
To evaluate the effect of two extended-release intravitreal (IV) hypopressure and neuroprotective treatments on refractive error and the neuroretina in rat eyes with chronic glaucoma. Cohort study. A total of 192 Long–Evans rat right eyes were analyzed: 42 healthy, 25 with glaucoma induced by episcleral vein sclerosis (G-evs), 60 G-evs treated with a single IV brimonidine–Laponite injection (G-evs–Brimonidine), 45 with glaucoma induced by anterior chamber microspheres (G-Ms), and 20 G-Ms treated with two IV latanoprost microsphere injections (G-Ms–Latanoprost). Assessments included intraocular pressure (IOP, rebound tonometry), retinal ganglion cell (RGC) function (electroretinography), diopter power, and neuroretinal structure (peripapillary retinal nerve fiber layer [pRNFL], RGC layer, and whole retina by optical coherence tomography) over 24 weeks. IOP, Latency and amplitude of electroretinography, diopters, thicknesses of the retinal layers. IV-treated glaucomatous eyes showed significantly lower IOP: G-evs–Brimonidine and G-Ms–Latanoprost vs. healthy eyes, and higher ERG b-wave amplitudes (both p < 0.001). All glaucomatous eyes exhibited dioptric power loss vs. healthy. G-evs–Brimonidine stabilized refraction and preserved RGC layer thickness (both p < 0.05). Conversely, G-Ms–Latanoprost caused greater myopization ( p = 0.011) but increased central retinal volume ( p < 0.001) and pRNFL thickness, exceeding even healthy eyes ( p = 0.001). Extended-release IV brimonidine and latanoprost lowered IOP and improved neuroretinal function and structure. A single IV brimonidine injection stabilized refraction and preserved RGC integrity, whereas repeated IV latanoprost injections induced myopization while enhancing central retinal and pRNFL thickness. These findings suggest that sustained-release IV therapy exerts both hypopressure and neuroprotective effects, while repeated injections may also modify ocular refractive status in glaucomatous eyes.
No takes yet. Share an insight, caveat, or question.
Bermúdez-Cervilla et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: